Aug 11 (Reuters) - Equillium Inc EQ.O:
EQUILLIUM ANNOUNCES UP TO $50 MILLION FINANCING TO ADVANCE EQ504, A NOVEL ARYL HYDROCARBON RECEPTOR MODULATOR, INTO THE CLINIC
EQUILLIUM INC - PHASE 1 STUDY INITIATION PLANNED MID-2026, DATA EXPECTED 6 MONTHS LATER
EQUILLIUM INC - EXPECTS CASH RUNWAY EXTENSION THROUGH 2027